Silence Therapeutics
OrganizationHeard in 4 episodes across 4 shows since Oct 2026
Silence Therapeutics plc is a clinical-stage biotechnology company developing precision-engineered medicines based on RNA interference (RNAi), particularly short interfering RNA (siRNA) therapeutics. Its pipeline targets diseases with significant unmet medical need, including hematologic and cardiometabolic conditions, using its proprietary delivery and gene-silencing technologies.
Episodes
This week
Expert statements
Share of the conversation
Mentions of Silence Therapeutics per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Oct 19 | 0.01‰ | 1 |
| Oct 20 | 0.03‰ | 2 |
| Oct 23 | 0.04‰ | 2 |
| Oct 26 | 0.04‰ | 1 |
Email alert
Email me when Silence Therapeutics comes up on a podcast
One email a week at most, with the new episodes that mention Silence Therapeutics. Free, no account needed, unsubscribe in one click.
What experts have said about Silence Therapeutics
2 statements · 2 positive
The Silent Therapeutics acquisition was valued at about $1.3 billion.
“the deal was for about $1.3 billion”
Open the episode · 120 - Breaking Biotech Week End Wrap Up - Oct 25th, 2026Listen at 3:33
Silence’s switch to polycythemia vera was an exceptionally good corporate decision.
“someone in silence, i don't know who, decided to switch to PV. And honestly, that's probably one of the best, best biotech corporate decisions ever made.”
Open the episode · Episode 200 - October 23, 2026Listen at 34:07
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
4 episodes featuring Silence Therapeutics, newest first
- Oct 26, 2026
Moderna trial leads biotech week in reviewBreaking BiotechOct 26, 2026 - Oct 23, 2026
AI challenges biotech’s old company modelBiotech HangoutOct 23, 2026 - Oct 20, 2026
China reshapes biotech deals as RNAi reaches the brainBioCentury This WeekOct 20, 2026 - Oct 19, 2026
SpaceX’s stock plans collide with trucking’s cost squeezeBrew MarketsOct 19, 2026